Back to Search
CHRISTOPHER DYKE, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1912360611Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
PMID 19460609·J Am Coll Cardiol·2009
4-observational
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
PMID 18506005·Circulation·2008
3-trial
High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulation.
PMID 18329494·J Thorac Cardiovasc Surg·2008
4-observational
The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.
PMID 18806012·Anesth Analg·2008
4-observational
Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
PMID 18270134·Heart Surg Forum·2008
8-other
Perioperative nesiritide and possible renal protection in patients with moderate to severe kidney dysfunction.
PMID 19026832·J Thorac Cardiovasc Surg·2008
8-other
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
PMID 17720385·Ann Thorac Surg·2007
3-trial
Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass.
PMID 17495258·J Cardiovasc Pharmacol Ther·2007
3-trial
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
PMID 17257990·Ann Thorac Surg·2007
3-trial
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
PMID 17101847·Circulation·2006
3-trial
Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial.
PMID 16931658·Anesth Analg·2006
3-trial
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain.
PMID 16580532·J Am Coll Cardiol·2006
8-other
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
PMID 16515924·J Thorac Cardiovasc Surg·2006
4-observational
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease.
PMID 15882894·Thromb Res·2006
2-rct
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
PMID 16515902·J Thorac Cardiovasc Surg·2006
4-observational
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
PMID 15748230·J Thromb Haemost·2005
3-trial
Use of bivalirudin as an anticoagulant during cardiopulmonary bypass.
PMID 16350384·J Extra Corpor Technol·2005
8-other
Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
PMID 15975385·Ann Thorac Surg·2005
8-other
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study.
PMID 15942583·J Thorac Cardiovasc Surg·2005
8-other
Separation of single-walled carbon nanotubes on silica gel. Materials morphology and Raman excitation wavelength affect data interpretation.
PMID 15783233·J Am Chem Soc·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- WALTER REED NATIONAL MILITARY CTR, 8901 WISCONSIN AVENUE
BETHESDA, MD 20889 - Phone
- (301) 295-4440
Quick Facts
- NPI
- 1912360611
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile